Every Form 4 that Health In Tech, Inc. (HIT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow HIT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HIT filings page.
Health In Tech, Inc. (HIT) reported that director Timothy Hayes sold Class A Common Stock in two recent transactions. On September 11, 2026 he sold 12,000 shares at $0.91 per share, and on September 9, 2026 he sold 5,730 shares at $0.93 per share, for total reported sales of 17,730 shares, all held directly. No Rule 10b5-1 trading plan is reported for these sales, and the filing does not state his remaining shareholdings.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin reported a disposition of Class A Common Stock related to tax withholding. On 2026-08-13, 28,183 shares of Class A Common Stock were surrendered to the company at $1.06 per share to satisfy tax withholding and remittance obligations arising from the vesting of previously granted restricted shares. After this transaction, Qian LinLin directly holds 8,998,392 Class A Common Stock, consisting of 938,743 restricted shares and 8,059,649 unrestricted shares. The reported total excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase Class A Common Stock.
Health In Tech, Inc. director and Chief Executive Officer Tim Donald Johnson reported a code F transaction involving restricted Class A Common Stock. On 2026-08-13, 46,327 shares of Class A Common Stock were surrendered to the company at $1.06 per share to satisfy tax withholding and remittance obligations arising from the vesting of restricted shares.
After this withholding transaction, Johnson directly holds 23,334,365 Class A shares, consisting of 842,491 restricted and 22,491,874 unrestricted Class A shares. In addition, the disclosure notes that this figure excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase Class A Common Stock.
Health In Tech, Inc. officer Hasan Zain Syed reported a disposition of 4,007 shares of Class A Common Stock on 2026-08-13 at $1.06 per share. The shares were surrendered to cover tax withholding related to vesting of previously granted restricted stock. After this tax-withholding disposition, Syed directly holds 200,211 shares, including 179,326 restricted and 20,885 unrestricted shares of Class A Common Stock.
Health In Tech, Inc. reported that Chief Growth Officer Hasan Zain Syed surrendered 4,084 shares of Class A Common Stock on July 15, 2026 to the company to satisfy tax withholding obligations related to vesting of restricted stock. The shares were valued at $1.04 each. After this tax-withholding disposition, Syed directly holds 204,218 Class A shares, including 189,249 restricted and 14,969 unrestricted shares.
Health In Tech, Inc. reports that CEO Tim Donald Johnson had 47,217 Class A Common shares withheld at $1.04 per share to satisfy tax obligations tied to vesting restricted stock. After this tax-withholding disposition, he directly holds 23,380,692 Class A shares, including 911,932 restricted and 22,468,760 unrestricted shares; this excludes Class B shares and options.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin surrendered 28,725 Class A Common shares on July 15, 2026 to the issuer to satisfy tax withholding tied to vesting of restricted stock. After this, LinLin directly owns 9,026,575 Class A shares, including 984,340 restricted and 8,042,235 unrestricted, and also holds 2,700,000 Class B shares and 711,510 options that are excluded from this Class A total.
Shrestha Sanjay K reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Sanjay K. Shrestha received a grant of 18,867 restricted shares of Class A Common Stock on July 8, 2026 under the Health in Tech Equity Incentive Plan. The restricted stock vested as of the grant date, and his direct holdings increased to 101,200 shares following this award.
Howard William D. reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Howard William D. received a grant of 18,867 restricted shares of Class A Common Stock on July 8, 2026 under the Health in Tech Equity Incentive Plan. The grant is reported at $1.06 per share, and his direct holdings after the award total 138,510 shares. The restricted stock vested as of the grant date.
Hayes Timothy reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Hayes Timothy received a grant of 18,867 restricted shares of Class A Common Stock at $1.06 per share under the Health in Tech Equity Incentive Plan. The restricted stock vested as of the grant date, bringing his direct holdings to 138,510 shares.
Health In Tech, Inc. Chief Growth Officer Hasan Zain Syed reported a routine tax-related share disposition. On the vesting of previously granted restricted Class A Common Stock, he surrendered 4,045 shares at $1.05 per share to cover tax withholding and remittance obligations. After this transaction, he directly holds 208,302 Class A shares, including 199,288 restricted and 9,014 unrestricted shares. This was not an open-market sale but a compensation-related tax withholding event.
Health In Tech, Inc. Chief Executive Officer and major shareholder Tim Donald Johnson reported a tax-related share disposition. He surrendered 46,768 shares of Class A Common Stock to the company at $1.05 per share to cover tax withholding tied to vesting restricted stock, rather than selling shares on the open market.
After this transaction, he directly holds 23,427,909 Class A shares, consisting of 984,353 restricted and 22,443,556 unrestricted shares. The footnotes also state that this figure excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase Class A shares.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin reported a disposition of 28,451 shares of Class A Common Stock on June 15, 2026. These shares were surrendered to the company to satisfy tax withholding obligations tied to the vesting of restricted stock, not sold in the open market.
After this tax-withholding disposition, LinLin directly holds 9,055,300 Class A shares, consisting of 1,030,065 restricted shares and 8,025,235 unrestricted shares. The footnotes also state that this figure excludes 2,700,000 shares of Class B Common Stock and 711,510 stock options.
Lockett Jonathan Del reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. Chief Strategy Officer Jonathan Del Lockett received a grant of 50,000 restricted shares of Class A Common Stock under the Health In Tech Equity Incentive Plan. These shares are subject to performance-based milestones and will be forfeited if those milestones are not achieved.
If the first milestone is met by on or before July 1, 2026, 20,000 shares will vest in equal monthly installments over 12 months. If a second milestone is met by on or before August 15, 2026, the remaining 30,000 shares will vest in equal monthly installments over 12 months. Following this award, he directly holds 143,539 shares, consisting of 78,985 unrestricted and 64,554 restricted shares, and also holds options to purchase 165,085 additional shares.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin reported a tax-related share disposition. On May 14, 2026, she surrendered 23,324 shares of Class A Common Stock at $1.23 per share to the company to satisfy tax withholding obligations tied to vesting restricted stock.
After this transaction, she directly holds 9,083,751 Class A shares, including 1,060,738 restricted and 8,023,013 unrestricted shares. The filing notes this does not include 2,700,000 Class B shares or 711,510 stock options.
Health In Tech, Inc. Chief Executive Officer and 10% owner Tim Donald Johnson reported a tax-related share disposition. He surrendered 39,924 shares of Class A Common Stock at $1.23 per share to the company to satisfy tax withholding obligations tied to vesting restricted stock awards.
After this transaction, he directly holds 23,474,677 Class A shares, consisting of 1,037,478 restricted and 22,437,199 unrestricted Class A shares. This was a tax-withholding disposition rather than an open-market sale.
Health In Tech, Inc. Chief Growth Officer Hasan Zain Syed reported a compensation-related share disposition tied to tax withholding. On restricted stock vesting, he surrendered 4,205 shares of Class A Common Stock at $1.23 per share to cover tax obligations rather than selling them in the market.
After this transaction, Syed directly holds 212,347 Class A shares, including 205,680 restricted shares and 6,667 unrestricted shares. This filing reflects routine tax withholding associated with previously reported restricted stock awards.
Health In Tech, Inc. director and Chief Executive Officer Tim Donald Johnson reported a tax-related share disposition. On April 15, 2026, he surrendered 35,140 shares of Class A Common Stock at $1.50 per share to cover withholding and remittance obligations triggered by the vesting of restricted stock.
After this tax-withholding disposition, he directly holds 23,514,601 Class A shares, consisting of 1,079,624 restricted and 22,434,977 unrestricted Class A shares, and this figure excludes 9,000,000 Class B shares and 734,707 stock options.
Health In Tech, Inc. Chief Growth Officer Hasan Zain Syed surrendered 3,448 shares of Class A Common Stock at a price of $1.50 per share to the company to cover tax withholding on vested restricted stock. Following this tax-withholding disposition, he directly holds 216,552 Class A shares, including 211,552 restricted shares and 5,000 unrestricted shares.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin reported a routine tax-related share disposition. On the vesting of previously granted restricted Class A Common Stock, 21,480 shares were surrendered to the company at $1.50 per share to satisfy tax withholding and remittance obligations, rather than sold on the open market.
After this tax-withholding disposition, LinLin directly holds 9,107,075 shares of Class A Common Stock, consisting of 1,086,284 restricted shares and 8,020,791 unrestricted shares, while separately excluding 2,700,000 shares of Class B Common Stock and 711,510 options to purchase Class A Common Stock.
Health In Tech, Inc. Chief Executive Officer and 10% owner Johnson Tim Donald reported a compensation-related share transaction. On the vesting of restricted Class A Common Stock, he surrendered 35,140 shares at $1.50 per share to the company to satisfy tax withholding obligations. This Form 4 characterizes the move as a tax-withholding disposition, not an open-market sale, and indicates he continues to hold a substantial direct position in Class A Common Stock after the transaction.
McStravock John reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. reported that General Counsel John McStravock received a grant of 5,000 restricted shares of Class A Common Stock as equity compensation. These shares were granted at no cash cost to him.
The restricted shares will vest in equal monthly installments over a twelve-month period starting on April 6, 2026, as long as he continues to serve with the company through each vesting date. After this grant, he holds 5,000 Class A shares directly.
Shrestha Sanjay K reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Sanjay K. Shrestha received a grant of 13,598 restricted shares of Class A Common Stock, valued at $1.36 per share, as compensation under the Health in Tech Equity Incentive Plan. The restricted stock vested on the grant date, bringing his direct holdings to 82,333 shares.
Howard William D. reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Howard William D. received a grant of 13,598 restricted shares of Class A Common Stock, valued at $1.36 per share, as equity compensation under the Health in Tech Equity Incentive Plan. The restricted shares vested as of the grant date, and he now directly holds a total of 119,643 Class A Common shares.
Hayes Timothy reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Timothy Hayes received a grant of 13,598 restricted shares of Class A Common Stock on April 8, 2026 under the Health in Tech Equity Incentive Plan. The filing reports the transaction at $1.36 per share.
The footnote states these restricted shares vested as of the grant date, meaning they became fully owned immediately. Following this equity award, Hayes directly holds 119,643 shares of Class A Common Stock.
Health In Tech, Inc. reported that Chief Growth Officer Hasan Zain Syed received 200,000 restricted shares of Class A common stock on January 6, 2026 under the Health in Tech Equity Incentive Plan. These shares are tied to two proposed issuer transactions. Half of the grant vests in equal monthly installments over 12 months starting at the closing of the first transaction, and the other half vests monthly over 12 months starting at the closing of the second transaction, in each case subject to continued service. If either transaction does not close within 24 months after January 6, 2026, the unvested shares relating to that transaction will be automatically forfeited without payment. Following this grant, Syed beneficially owns 220,000 restricted shares of Class A common stock, held directly.
Health In Tech, Inc. reported that Chief Executive Officer, director and 10% owner Tim Johnson received a grant of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 at a price of $0 per share under the Health In Tech Equity Incentive Plan. The grant is tied to two proposed issuer transactions: half of the shares vest in equal monthly installments over 12 months starting at the closing of the first transaction, and the other half vest monthly over 12 months starting at the closing of the second transaction, in each case subject to continued service.
If either transaction does not close within 24 months after January 6, 2026, any unvested shares relating to that transaction will be automatically forfeited without consideration. Following this award, Johnson beneficially owns 23,549,741 shares of Class A Common Stock, including 1,126,130 restricted shares and 22,423,611 unrestricted shares.
Health In Tech, Inc. officer and director LinLin Qian reported an award of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 under the Health in Tech Equity Incentive Plan at a price of $0 per share. The grant is tied to two proposed issuer transactions, with half of the shares vesting in equal monthly installments over 12 months after the closing of the first transaction and the other half vesting monthly over 12 months after the closing of the second transaction, subject to continued service.
If either transaction does not close within 24 months after January 6, 2026, any unvested shares related to that transaction will be forfeited without consideration. Following this grant, Qian beneficially owns 9,128,555 Class A shares, including 1,119,130 restricted shares and 8,009,425 unrestricted shares, and also holds but does not count here 2,700,000 Class B shares and 711,510 options to purchase Class A shares.
Health In Tech, Inc. (HIT) reported an insider equity award. On 11/05/2025, the company’s CISO, Michael Clarkson, received 8,000 restricted shares of Class A Common Stock coded “A” at a price of $0.00 under the Health in Tech Equity Incentive Plan. Following the grant, he beneficially owns 8,000 shares, held directly.
The restricted shares vest in equal monthly installments over twelve months, commencing on November 1, 2025, contingent on continued service through each vesting date. This filing reflects routine equity compensation for an officer rather than an open‑market transaction.
Insider transactions by director William D. Howard at Health In Tech, Inc. (HIT)
The reporting person, a director, disposed of 28,159 restricted shares of Class A common stock that were subject to pro-rata forfeiture upon the annual stockholders meeting held on 10/03/2025. Five days later, on 10/08/2025, the director acquired 5,730 restricted shares at a price of $3.49 per share under the company’s Equity Incentive Plan. After these transactions the director beneficially owns 106,045 shares of Class A common stock.
Insider transactions by Director Timothy Hayes at Health In Tech, Inc. (HIT)
Director Timothy Hayes reported a disposition and a later acquisition of Class A common stock. On 10/03/2025 he disposed of 28,159 restricted shares that were forfeitable pro rata at the issuer's annual meeting, leaving 100,315 shares beneficially owned. On 10/08/2025 he acquired 5,730 restricted shares at a purchase price of $3.49 per share; those newly granted restricted shares vest quarterly from the grant date subject to continued service. The filing shows Hayes remains a significant insider and that his post-transaction holdings total 106,045 shares, combining previously owned and newly granted restricted stock.
Insider transactions by Director Sanjay K. Shrestha at Health In Tech, Inc. (HIT). The form reports a disposition of 65,469 Class A common shares on 10/03/2025 that were restricted shares subject to forfeiture tied to the annual stockholders meeting. The filing also shows an acquisition of 5,730 restricted Class A shares on 10/08/2025 at a purchase price of $3.49 per share; those restricted shares vest quarterly from the grant date with continued service. After these transactions the reporting person beneficially owned 68,735 Class A shares on a direct basis.
Health In Tech, Inc. (HIT) reported an insider grant to Tim Johnson, who is the company's Chief Executive Officer, a director and a >10% owner. On 09/24/2025 Mr. Johnson was granted 80,000 restricted shares of Class A Common Stock under the Health in Tech Equity Incentive Plan at no cash price. The restricted shares vest in three equal tranches, each vesting monthly over a 12-month period tied to milestones: signing a letter of intent or MOU for an initiative, proof-of-concept or beta launch, and full commercial launch. After the grant Mr. Johnson beneficially owns 22,549,741 shares (which the form notes includes 137,495 restricted shares and 22,412,246 Class A shares); the filing excludes 9,000,000 Class B shares and 734,707 options.
LinLin Qian, who serves as Chief Financial Officer, a director and a >10% owner of Health In Tech, Inc. (HIT), received a grant of 80,000 restricted shares of Class A Common Stock on 09/24/2025 at a reported price of $0. Following the grant, the reporting person beneficially owns 8,128,555 shares, which the filing states includes 130,495 restricted shares and 7,998,060 Class A shares (the filing separately excludes 2,700,000 Class B shares and 711,510 options). The restricted shares vest in three equal tranches tied to an initiative: monthly over 12 months after a letter of intent, monthly over 12 months after proof-of-concept or beta launch, and monthly over 12 months after full commercial launch.